Pharma

2026 with glowing coin and dollar sign

Pharma

PwC projects continued growth for rest of 2026, fueled by M&A

With pharma and life sciences deals surpassing $65 billion in Q1, analysts from PwC have declared the “biopharma ecosystem is back to full health.”

Kevin Dunleavy Jun 17, 2026 5:00am

United States and United Kingdom flag

FDA, MHRA strengthen transatlantic alliance with liaison program

Jun 16, 2026 11:19am

Beyond China and Japan How biopharma is expanding rare disease access across Asia-Pacific

Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific

Brought to you by DKSH

Ester Banque Moderna CCO

Steeling for new launches, Moderna hires Novartis vet as new CCO

Jun 16, 2026 10:35am

ASCO 2026 showed that precision oncologys next challenge is translation

Precision oncology’s next challenge is translation

Brought to you by Thermo Fisher Scientific

rebrand branding

Stealth BioTherapeutics removes cloak to become Mighty

Jun 16, 2026 8:48am